Advaxis, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Princeton NJ United States (2002)
Status: Acquired by BioSight Ltd. (2021)

Organization Overview

First Clinical Trial
2010
NCT01116245
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Advaxis, Inc. | Director, Clinical Operations, Advaxis Inc